Search Results
Oct 28, 2025, 05:05 ET LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
represents a completely novel drug design in stroke treatment—combining thrombolytic and neuroprotective properties into a single agent," said Thomas Devlin, MD, PhD, Professor of Neurology at the University of Tennessee Health Science Center and Principal Investigator of the study. "The positive results of this
More news about: Lumosa Therapeutics Co., Ltd.
Oct 28, 2025, 04:20 ET LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
represents a completely novel drug design in stroke treatment—combining thrombolytic and neuroprotective properties into a single agent," said Thomas Devlin, MD, PhD, Professor of Neurology at the University of Tennessee Health Science Center and Principal Investigator of the study. "The positive results of this
More news about: Lumosa Therapeutics Co., Ltd.
Oct 28, 2025, 03:01 ET MemorialCare Hospitals Honored Among Nation's Top Hospitals for Clinical Excellence by Healthgrades
nation's top-performing hospitals in key service areas, helping consumers find high quality care tailored to their specific needs," said Alana Biggers, MD, MPH, medical advisor at Healthgrades. "We're proud to recognize MemorialCare for its consistently superior outcomes in key service areas, including prostate
More news about: MemorialCare
Oct 27, 2025, 20:53 ET Increasing Demand for Justice Fuels Herman Law Headquarters Expansion in Boca Raton, Florida
offices including Manhattan, NY, Buffalo, NY, Princeton, NJ, Sacramento, CA, Los Angeles, CA, San Diego, CA, Boca Raton, FL and opening soon in Baltimore, MD. As a vital resource for survivors of sexual abuse, the office's growth underscores a rising call for expanded legal support and justice across the country.
More news about: Herman Law
Oct 27, 2025, 16:30 ET Vapotherm HVT® 2.0 Earns DoD Authority to Operate Certification, Advancing Secure Respiratory Support for Military and VA Hospitals
Contact: Jessica Whittle, MD PhD Chief Medical Officer | VP Clinical
More news about: Vapotherm, Inc.
Oct 27, 2025, 14:24 ET Music therapy during surgery reduces anesthetic use and stress responses
"This study shows the real potential of music to improve anesthetic care, but we must go further," said Joseph J. Schlesinger, MD, FCCM, Professor of Anesthesiology, Critical Care Medicine, Hearing & Speech Sciences, and Biomedical Engineering at Vanderbilt University Medical
More news about: International Association for Music & Medicine
Oct 27, 2025, 14:00 ET ISPE Names CSL Behring the 2025 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Project Aurora Plasma Base Fractionation Facility (Facility F)
celebrates its 20th anniversary NORTH BETHESDA, Md., Oct. 27, 2025 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (
More news about: ISPE
Oct 27, 2025, 11:15 ET Neurotronic Announces Presentation of First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension
highlighted the following key study outcomes in their presentations: NECTAR III – Dr. Ajay J. Kirtane, MD, Columbia University Medical Center The 30-day procedural safety endpoint
More news about: Neurotronic
Oct 27, 2025, 10:51 ET Emergency Physicians Share Tips for a Safe Halloween
"Halloween is one of the busiest nights of the year for many emergency physicians," said L. Anthony Cirillo, MD, FACEP, president of ACEP. "A few precautions can help make sure your fright night celebration does not include an unplanned medical scare."
More news about: American College of Emergency Physicians
Oct 27, 2025, 10:00 ET Lupus Foundation of America Honors Outstanding Achievements in Lupus Research
lupus researchers at the 20th Anniversary Evelyn V. Hess Reception. Karen Costenbader, MD, MPH, Brigham and Women's Hospital, was honored with the 2025 Evelyn V. Hess Award, and Andrea Fava, MD, Johns Hopkins University, received the 2025 Mary Betty Stevens Young Investigator Prize at the prestigious
More news about: Lupus Foundation of America, Inc.
Oct 27, 2025, 09:00 ET Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
advanced therapy with CAVT can rapidly and safely improve recovery of the right heart compared to conventional anticoagulation therapy," said Robert Lookstein, MD, MSc; co-global principal investigator of the STORM-PE RCT and professor of radiology and surgery at Icahn School of Medicine at Mount Sinai. "STORM-PE
More news about: Penumbra, Inc.
Oct 27, 2025, 08:58 ET MIUDELLA® Hormone-Free Copper Intrauterine System (IUS) Phase 3 Data Publication in Contraception Honored with Daniel Mishell, Jr. MD Outstanding Article Award at Society of Family Planning Annual Meeting
Principal Investigator David K. Turok, MD, MPH, and the article's lead author Mitchell Creinin, MD -- as well as to the entire Copper 175mm2 IUD Phase 3 Clinical Investigator Group -- and the women nationwide who were involved in the study," said Kelly Culwell, MD, Head of Research and Development,
More news about: Sebela Pharmaceuticals Inc
Oct 27, 2025, 08:54 ET Brave Healer Productions Releases Clear Trauma Now: A Powerful Solution for Getting Unstuck
BETHESDA, Md., Oct. 27, 2025 /PRNewswire/ -- Brave Healer Productions is proud to announce the release of
More news about: Brave Healer Productions
Oct 27, 2025, 08:45 ET K. Hovnanian Homes Celebrates New-Home Community Magnolia Hill
PERRY HALL, Md., Oct. 27, 2025 /PRNewswire/ -- K. Hovnanian Homes is proud to announce a ribbon cutting event and grand opening of Magnolia Hill, a brand-new community in beautiful Perry Hall, MD. These villa-style homes offer up to
More news about: Hovnanian Enterprises, Inc.
Oct 27, 2025, 08:30 ET Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development, Upcoming Webinar Hosted by Xtalks
Hunter, PhD, Senior Scientific Expert, Neurodevelopmental and Rare Disease, and Epilepsy; Thomas Fuerst, PhD, Chief Science Officer; and Vic Patel, MD, PhD, Vice President & Chief Medical Officer, Cardiology, for the live webinar on Wednesday, November 12, 2025, at 11am EDT (5pm CET/EU-Central).
More news about: Xtalks
Oct 27, 2025, 08:04 ET 29 Physicians from Virginia Cancer Specialists Named to Washingtonian Magazine's Top Doctors List 2025
Christie, MD, FACP, Oncology/HematologyAjay Dar, MD, Oncology/Hematology
More news about: Virginia Cancer Specialists
Oct 27, 2025, 08:00 ET SimBioSys Showcased on ABC News Digital and Good Morning America Highlighting the Power of AI-Driven 3D Visualization in Breast Cancer Surgery
The piece followed patient Brooke Davis and her care team at Mercy Cedar Rapids, led by Vincent Reid, MD, FACS, Chairman of Surgery, as they used TumorSight Viz to apply advanced AI modeling to Brooke's breast MRI data—quantifying tumor size, shape, and spatial
More news about: SimBioSys
Oct 27, 2025, 08:00 ET Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Fawaz Al-Muft, MD, Global Chair of Mission Thrombectomy. "By combining our clinical network, training programs, and global advocacy reach with Remedy's groundbreaking
More news about: Remedy Robotics, Inc.
Oct 27, 2025, 08:00 ET Pancreatic Cancer Clinical Trial Data for Diakonos Oncology's DOC1021 Cell-Based Immunotherapy to be Presented at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
announced a poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, being held November 5-9 in National Harbor, MD.
More news about: Diakonos Oncology
Oct 27, 2025, 08:00 ET New Oshi Health Research at ACG 2025 Demonstrates Improved Outcomes and Cost Savings At Scale Through Virtual, Multidisciplinary GI Care
better symptom control and quality of life, while lowering the likelihood of costly urgent care escalations and avoidable care," said Sameer Berry, MD, MBA, Co-founder and Chief Medical Officer at Oshi Health. "Because of our patient volume, excellence in managing complex cases, and clinicians practicing
More news about: Oshi Health
Oct 27, 2025, 07:47 ET Parkland Reports 2025 Third Quarter Results and Provides Update on the Sunoco Transaction
MD&A and Annual Consolidated Financial Statements The Management's Discussion and Analysis for the three and nine months ended September 30, 2025 (the "Q3 2025 MD&A") and Interim Condensed Consolidated Financial
More news about: Parkland Corporation
Oct 27, 2025, 07:45 ET New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
Alzheimer's disease pathology, supporting diagnosis and advancing patient care for Alzheimer's disease in the intended use patients," said Michael Racke, MD, a board-certified neurologist and Senior Medical Director of Neurology, Quest Diagnostics. "Our analysis also suggests that blood-based testing can achieve
More news about: Quest Diagnostics
Oct 27, 2025, 07:30 ET TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years
TREMFYA®. "Crohn's disease is a chronic condition that can greatly impact a patient's quality of life," said David Rubin, MD, Director of the Inflammatory Bowel Disease Center at the University of Chicago.e "These results show that guselkumab can provide endoscopic
More news about: Johnson & Johnson
Oct 27, 2025, 07:29 ET Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic
pharmaceutical ingredient with protection until 2041 ANNAPOLIS, Md., Oct. 27, 2025 /PRNewswire/ --
More news about: Alphyn Biologics, Inc.
Oct 27, 2025, 07:14 ET Xcellerant Ventures and Jetstream Founder John Shufeldt Establish the John Shufeldt School of Medicine and Medical Engineering at Arizona State University
establishes a groundbreaking medical school that unites medicine, engineering, and entrepreneurship. The school will prepare students to earn both an MD and a Master of Science in Medical Engineering, training the next generation of clinician-innovators equipped to transform patient care through technology,
More news about: Xcellerant Ventures